CONTACT US
Share: Share on Facebook Share on Twitter Share on LinkedIn I recommend visiting cushmanwakefield.com to read:%0A%0A {0} %0A%0A {1}

Life Sciences: COVID-19 Report

Jolanta Campion • 6/26/2020

Life sciences covid-19 (image)

The life sciences sector holds a unique place in the disruptive new landscape resulting from COVID-19. Like most businesses, it has been negatively impacted by the lockdowns, but it is also the sector expected to produce a vaccine or treatment that will mitigate the pandemic. 12 featured local market snapshots give an overview into the life sciences sector and the impact of the pandemic, establishing a baseline for analyzing potential impact in the months to come. 

The Life Sciences: COVID-19 Report explores the life science industry's unique position in the COVID-19 landscape, including: 

  • Pre-pandemic situation 
  • Sector employment trends 
  • Fight against the virus
  • Financial performance and real estate implications
  • Key market highlights  

Download the report to learn more.

 

Insights in your inbox
Subscribe to get Cushman & Wakefield's latest Recovery Readiness updates and insights. We also look forward to hearing from you to see how we can help.
Subscribe Contact us today

GET THIS REPORT

Life sciences covid-19 (image)

Download

Related Insights

Asia REIT Market Insight 2023-2024
Research • Investment / Capital Markets

Asia REIT Market Insight 2023-2024

We are thrilled to present the 8th annual edition of Cushman & Wakefield’s Asia REIT Market Insight series! This in-depth report offers a comprehensive analysis of the five largest REIT markets in Asia: Japan, Singapore, Hong Kong China (“Hong Kong”), the Chinese mainland, and India.

Catherine Chen • 7/22/2024
Greensboro (image)
MarketBeat

Greensboro / Winston-Salem

Cushman & Wakefield MarketBeat reports analyze quarterly economic and commercial real estate activity including supply, demand and pricing trends at the market and submarket levels.
JP Price • 7/19/2024
life sciences
Research

Life Sciences Update

The life sciences industry enters 2024 with measured optimism, signaling that the sector has reverted to its long-term trend for growth. A flurry of recent announcements, from strong initial public offerings to exciting new mergers and acquisitions, has breathed new life into the industry.
Sandy Romero • 3/6/2024
With your permission we and our partners would like to use cookies in order to access and record information and process personal data, such as unique identifiers and standard information sent by a device to ensure our website performs as expected, to develop and improve our products, and for advertising and insight purposes.

Alternatively click on More Options and select your preferences before providing or refusing consent. Some processing of your personal data may not require your consent, but you have a right to object to such processing.

You can change your preferences at any time by returning to this site or clicking on Privacy & Cookies.
MORE OPTIONS
AGREE AND CLOSE
These cookies ensure that our website performs as expected,for example website traffic load is balanced across our servers to prevent our website from crashing during particularly high usage.
These cookies allow our website to remember choices you make (such as your user name, language or the region you are in) and provide enhanced features. These cookies do not gather any information about you that could be used for advertising or remember where you have been on the internet.
These cookies allow us to work with our marketing partners to understand which ads or links you have clicked on before arriving on our website or to help us make our advertising more relevant to you.
Cookie preferences
Agree All
Reject All
SAVE SETTINGS
Essential
Non Essential
Marketing